Accuray | ARAY - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Abbott USD 2.36B 178M 2025-12
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Boston Scientific USD 938M 3M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Inogen USD -6.06M 467K 2024-09
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -2.19M 20.07M 2025-12
Surmodics USD -5.9M 1.61M 2025-06
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Trinity Biotech USD -5.06M 10.74M 2025-09